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A B S T R A C T  
Objective: In the era of increasing antibiotic resistance, associated with increasing hospital stay and morbidity, the 
purpose was to define guidelines for antibiotics in different clinical situations. 
Patients and Methods: This study was conducted at Khan Research Laboratories Hospital, Islamabad, Pakistan, from 
July 2014 to December 2016. 3277 patients admitted in Medical, Surgical, Gynaecology & Obstetrics, ENT, Eye and 
Dental departments were included. Positive cultures from different sources including blood, urine, pus, central venous 
lines, bronchial washings and cervical swabs were taken. Age, gender, common pathogens, their sensitivity and 
resistance to 27 antimicrobial drugs were taken into account. Statistical Package for Social Sciences (SPSS) version 20 
was used for data analysis. 
Results: 53.1% (n=1738) were females while 46.9% (n=1539) were males.2800 samples were available for analysis. 
Majority of the patients belonged to Medical ward, 56.9% (n=1864). Major source of culture was urine, 38.3% (n=1073). 
Escherichia coli (E. coli) was the most common isolate 51.3% (n=1436) followed by Staphylococcus aureus 19.9% 
(n=558). E. coli showed maximum sensitivity to Imipenem i.e. 94% (n=1349) followed by Amikacin, 93% (n=1335). It was 
resistant to ceftriaxone (77%).Staphylococcus aureus showed maximum sensitivity to Linezolid and Vancomycin i.e. 
98% (n=548) followed by Chloramphenicol 84% (n=470), while being resistant to ciprofloxacin and levofloxacin (54%). 
Klebsiella pneumoniae showed maximum sensitivity to Imipenem i.e. 75%, while showing resistance to 
Amoxicillin/Clavulanic Acid (95%) and Ceftriaxone (80%).Staphylococcus epidermidis showed maximum sensitivity to 
Linezolid i.e.99%. Pseudomonas aeruginosa showed maximum sensitivity to Piperacillin and Tazobactam i.e. 76% . 
Acinetobacter baumannii showed maximum sensitivity to Colistin i.e. 91%.Salmonella typhi showed maximum sensitivity 
to Ceftriaxone i.e. 99% while resistance to Ciprofloxacin (94%).Enterococcus faecalis showed maximum sensitivity to 
Linezolid i.e.100% and Salmonella Paratyphi A showed maximum sensitivities to Cefixime and Ceftriaxone i.e 100% 
Conclusion: Antibiotic resistance is emerging. Rationale use of antibiotics is required to curtail the surge of antibiotic 
resistance. There is also a need to modify treatment guidelines in different clinical situations based on local sensitivity 
and resistance patterns in order to reduce hospital stay, morbidity and mortality. 
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I n t r o d u c t i o n  
 
Antimicrobial resistance is recognized as one of the 
greatest threats to human health worldwide.1 Drug-
resistant infections take a staggering toll in the United 
States (US) and across the globe. Just one organism, 
methicillin-resistant Staphylococcus aureus (MRSA), kills 
more Americans every year (∼19,000) than emphysema, 
HIV/AIDS, Parkinson's disease, and homicide combined.2  
Antibiotic resistance is an increasing crisis as both the 
range of microbial antibiotic resistance in clinical settings 
expands and the pipeline for development of new 
antibiotics contracts.3 The first isolation of a bacterium, 
enables the design of experimental models to analyze 
virulence and to complete Koch's criteria, thereby 
establishing a link between microorganisms and infectious 
diseases.4 Antimicrobial agents have been greatly 
important cornerstones of clinical medicine since the 
second half of the 20th century and have saved a great 
number of people from life-threatening bacterial 
infections. However, the last decade of  20th century and 
the first decade of the 21th century have witnessed the 
emergence and spread of antibiotic resistance in 
pathogenic bacteria around the world, and the 
consequent failure of antibiotic therapy, especially in 
intensive care units (ICUs), which has led to hundreds of 
thousands of deaths annually.5 A pure bacterial culture 
remains essential for the study of its virulence, its 
antibiotic susceptibility, and its genome sequence in order 
to facilitate the understanding and treatment of caused 
diseases.  
The first culture conditions empirically varied incubation 
time, nutrients, atmosphere, and temperature; culture was 
then gradually abandoned in favor of molecular methods. 
The rebirth of culture in clinical microbiology was 
prompted by microbiologists specializing in intracellular 
bacteria.6 Bacterial culture also enables the study of the 
antibiotic susceptibility of bacteria and is the first step in 
establishing recommendations for effective treatment. 7,8 
A recent study of antibiotic prescribed in primary care for 
urinary tract infection(UTI) in Ireland identified that only 
55% of antibiotic prescriptions could be interpreted as 
appropriately targeted when evaluated against the 
laboratory report on the urine sample.9 The theme of 
World Health Day 2011 “antimicrobial resistance: no 
action today, no cure tomorrow” highlighted antimicrobial 
resistance as a major issue. The pathogens currently 
presenting the biggest problem in terms of antimicrobial 
resistance as the ESKAPE pathogens: Enterococcus 
faecium (E. faecium), Staphylococcus aureus (S. 
aureus), Klebsiella pneumoniae (K. 
pneumoniae), Acinetobacter baumannii (A. 
baumannii), Pseudomonas aeruginosa (P. aeruginosa), 
and Enterobacter species.10,11 Multiple drug resistance 
(MDR) is defined as non-susceptibility to at least one 
agent in three or more antimicrobial categories. 
Extensively drug resistant (XDR) is defined as non-
susceptibility to at least one agent in all but two or fewer 
antimicrobial categories (i.e. bacterial isolates remain 
susceptible to only one or two categories). Pan-drug 
resistant (PDR) is defined as non-susceptibility to all 
agents in all antimicrobial categories.12 
There has probably been a gene pool in nature for 
resistance to antibiotics. For most microbes that are 
antibiotic producers are resistant to their own antibiotic. In 
retrospect, it is not surprising that resistance to penicillin 
in some strains of staphylococci was recognized almost 
immediately after introduction of the drug in 1946. 
Likewise, very soon after their introduction in the late 
1940s, resistance to streptomycin, chloramphenicol and 
tetracycline was noted. By 1953, during a Shigella 
outbreak in Japan, a strain of the dysentery bacillus 
(Shigella dysentery) was isolated which was multiple drug 
resistant, exhibiting resistances to chloramphenicol, 
tetracycline, streptomycin and the sulfonamides. Over the 
years, and continuing into the present almost every 
known bacterial pathogen has developed resistance to 
one or more antibiotics in clinical use.13 
A study conducted in Ethiopia showed that 54.2% of eye 
swab cultures were positive for different bacterial 
pathogens.14 P.aeruginosa found in urinary tract infections 
showed 19% multi-drug resistant strains in a German 
study.15 In a study conducted in China, an opportunistic 
pathogen, A. baumannii showed more than 30% drug 
resistance to most of the antibiotics tested in the study.16  
In a study conducted in Karachi Pakistan, out of 312 
cultured specimens, 272 (87.17%) were found to be 
infected with 437 microbial organisms.17 While in a study 
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on blood cultures, out of 1824 blood cultures, 508 (27.9%) 
yielded microorganism growth.18 In another study, the 
frequency of MDR P. aeruginosa among all 
the Pseudomonas strains isolated was found to be 
22.7%.19 
In view of emerging resistance, we conducted our study to 
ascertain the presence of pathogens in different human 
sources, and their antimicrobial sensitivity and resistance. 
P a t i e n t s  a n d  M e t h o d s  
This study was conducted at Khan Research Laboratories 
Hospital, Islamabad, Pakistan, from July 2014 to 
December 2016. In total 3277 patients admitted in 
Medical, Surgical, Gynaecology & Obstetrics, ENT, Eye 
and Dental departments were included. Positive cultures 
from different sources including blood, urine, pus, central 
venous lines, bronchial washings and cervical swabs 
were taken. Age, gender, common pathogens, their 
sensitivity and resistance to 27 antimicrobial drugs were 
taken into account. The tested antimicrobials included 
Imipenem, Meropenem, Cefoperazone/Sulbactam, 
Pipercillin/Tazobactam, Trimethoprim/sulfamethoxazole 
(TMP/SMX), Pencillin G, Ampicillin, Amoxicillin/Clavulanic 
acid, Chloramphenicol, Vancomycin, Linezolid, Amikacin, 
Gentamicin, Nalidixic acid, Ciprofloxacin, Levofloxacin, 
Ofloxacin, Cefixime, Ceftriaxone, Ceftazidime, 
Cefoperazone, Cephradine, Tigecyclin, Doxycycline, 
Colistin, Nitrofurantoin and fosfomycin. The Bactec blood 
culture system produced by Becton Dickinson (Mountain 
View, CA, United States) was used. The Kirby-Bauer (KB) 
method was used for drug sensitivity testing on Müller-
Hinton agar. The results of the drug sensitivity tests were 
assessed according to the standards of the US Clinical 
and Laboratory Standards Institute (CLSI). All urine 
samples were cultured on cysteine lactose electrolyte 
deficient (CLED) medium. The plates were incubated at 
37 C for 24 hours and using gram staining, morphology 
and biochemical characteristics, bacteria was identified. 
Antimicrobial susceptibility testing was performed on all 
isolated bacteria by Kirby Bauer's disc diffusion method 
as per Clinical and Laboratory Standards Institute (CLSI) 
recommendations. Isolates were declared as sensitive or 
resistant on the basis of zone of inhibition following the 
Laboratory standards. Bronchial washing’s samples were 
weighed and processed with a 4-fold volume of 
dithiothreitol (Sputasol, Oxoid Ltd., Hants, UK) and were 
cultured. Sputum samples were serially diluted and plated 
on chocolate agar enriched, chocolate agar with 
bacitracin, Haemophilus-selective agar, blood agar, and 
MacConkey agar. Plates were incubated for 24-48 hours 
at 37°C and in 5% CO2 atmosphere. Microorganisms 
were identified by colony morphology, Gram staining and 
specific culture conditions. For CSF culture, 0.15 ml of 
uncentrifuged CSF specimen was inoculated onto each of 
one 5% sheep blood plate and one chocolate agar plate 
(Becton Dickinson Microbiology Systems, Cockeysville, 
Md.), and 1.0 ml was inoculated into 5 ml of BD blood 
culture bottles. Agar plates were incubated at 37°C in 5% 
carbon dioxide and examined daily for 3 days. Broth 
cultures were incubated at 37°C. Cervical swab 
specimens were placed in Blood Agar (BA) and 
Sabouraud Agar (SA) for 18-24 hr in 5% CO2 atmosphere 
at 37℃. Statistical Package for Social Sciences (SPSS) 
version 20 was used for data analysis. Data of study 
patients were stated as number of patients and 
percentages.  
R e s u l t s  
Present study comprised of 3277 patients. Total 
1738(53.1%) were females while 1539 (46.9%) were 
males. Only 176 (5.4%) patients were below 20 years of 
age, 1081 (32.9%) patients were between 20 to 50 years, 
1143 (34.9%) patients were between 50 to 70 years and 
877 (26.8%) patients were above 70 years. More than half 
1864 (56.9%) patients were admitted in Medical ward 
(Figure 1). 
 
Figure 1: Distribution of patients in different wards 
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Figure 2: Source of cultures 
Out of 3277 patients, culture samples of 2769 (84.5%) 
patients were available for analysis (Figure 2) 
Table 1 illustrates frequency of microorganisms isolated. 
As shown in the table, Escherichia coli (E. coli) was the 
most common isolate 51.3% (n=1436), followed by S. 
aureus 19.9% (n=558) (Table 1) 
Table: 1 Frequency of common isolates 
Organism Frequency (%) 
Escherichia coli 1436 (51.3) 
Staphylococcus aureus 558 (19.9) 
Klebsiella pneumonia 405 (14.5) 
Staphylococcus 
epidermidis 
325 (11.6) 
Pseudomonas aeruginosa 244 (8.7) 
Acinetobacter baumannii 233 (8.3) 
Salmonella typhi 228 (8.1) 
Enterococcus faecalis 121 (4.3) 
Salmonella paratyphi A 59 (2.1) 
 
Antimicrobial sensitivity and resistance of the above 
mentioned microorganisms have been shown in table 2 
D i s c u s s i o n  
We conducted our study to determine sensitivity and 
resistance patterns of microorganisms in different clinical 
settings. Susceptibility pattern of pathogens has been 
changing over the years, implying the need for periodic 
monitoring in order to decrease the number of therapeutic 
failures and boost an effort to arrest the growing 
occurrence of antibiotic resistance. Proper collection, 
transportation and inoculation are other steps required for 
enhancing bacterial growth on culture media. 
Microbiologists have to work in collaboration with 
clinicians in installing newer and appropriate antibiotic 
discs according to emerging resistance patterns and local 
antibiogram.  
In our study, E. coli was found to be the most 
predominant isolated organism (51.3%). In a study 
conducted in Saudi Arabia, E. coli was found to be the 
most common isolate (38.3%).20 In another study 
conducted in India, E. coli was also the most common 
isolate having frequency of 59.6%.21 This warrants the 
need of suspecting E. coli in different clinical conditions 
and starting appropriate empiric treatment targeting E. coli 
apart from other microorganisms. E. coli and K. 
pneumoniae showed greater resistance to Ampicillin, 
Amoxicillin and TMP/SMX, these results are comparable 
to  another study in which E.coli (34.6%), coagulase-
negative staphylococci (19.2%), P. aeruginosa (15.4%), 
and Klebsiella spp. (11.5%) were common bacterial 
isolates, where most of them were resistant against 
ampicillin, amoxicillin, tetracycline, TMP/SMX, and 
chloramphenicol.22 Of particular interest is the resistance 
to Ceftriaxone of E.coli(77%) and K.pneumoniae(80%) in 
this study. These two gram negative organisms showed 
greater sensitivity to three commonly chosen antibiotics 
Imipenem, Amikacin and Meropenem.According to a 
study conducted in Quaid-i-Azam University, Islamabad, 
the antibiotics showing greater susceptibility towards E. 
coli and K. pneumoniae isolates were imipenem, 
piperacillin-tazobactam, ampicillin-sulbactam and 
amikacin. The antibiotics having the highest resistance, 
particularly against the  Extended Spectrum Beta 
Lactamases (ESBLs) producers were 
amoxicillin/clavulanic acid, TMP/SMX, cefuroxime, 
cefpirome, ceftriaxone and ciprofloxacin and should be 
removed from the line of treatment for common urinary 
tract infections23, while a study conducted in Saudi Arabia 
showed that E.coli is more than 78% resistant to 
Amikacin.20 P. aeruginosa showed alarming resistance to 
the once commonly prescribed antibiotics including  
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Table 2: Sensitivity and resistance pattern of  Various Organism 
Escherichia coli (E.coli) (n=1436) 
Sensitivity Resistance 
Antibiotic n % Antibiotic n % 
Imipenem 1349 94 Ampicillin 1293 90 
Amikacin 1335 93 Cefixime 1136 79 
Meropenem 1250 87 Amoxicillin/Clavulanate 1111 77 
Cefoperazone/Sulbactam 1045 73 Ceftriaxone 1105 77 
Pipercillin/Tazobactam 979 68 TMP/SMX 1082 75 
Staphylococcus aureus (n=558) 
Linezolid 548 98 Penicillin G 535 96 
Chloramphenicol 470 84 Ampicillin 532 95 
Amikacin 457 82 Ciprofloxacin 304 54 
Doxycycline 447 80 Levofloxacin 299 54 
Vancomycin 548 98 Ofloxacin 245 44 
Klebsiella pneumoniae (n=405) 
Imipenem 304 75 Ampicillin 395 98 
Meropenem 297 73 Amoxillin/clavulanic acid 384 95 
Amikacin 270 67 Cefixime 336 83 
Cefoperazone/Sulbactam 210 52 Ceftriaxone 326 80 
Pipercillin/Tazobactam 181 45 TMP/SMX 300 74 
Staphylococcus epidemidis (n=325) 
Linezolid 323 99 Ampicillin 316 97 
Amikacin 294 90 Penicillin G 314 97 
Vancomycin 277 85 Ciprofloxacin 208 64 
Chloramphenicol 270 83 Levofloxacin 207 64 
Gentamicin 215 66 Ofloxacin 177 54 
Pseudomonas aeruginosa (n=244) 
Piperacillin/tazobactam 186 76 Levofloxacin 95 39 
Amikacin 183 75 Ciprofloxacin 90 37 
Cefoperazone/sulbactam 182 75 Ceftazidime 80 33 
Imipenem 179 73 Cefoperazone 80 33 
Gentamicin 164 67 Gentamicin 74 30 
Acinetobacter baumannii (n=233) 
Colisitin 213 91 Amoxillin/clavulanic acid 231 99 
Tigecycline 187 80 Ceftriaxone 227 97 
Gentamicin 91 39 Ampicillin 226 97 
Amikacin 70 30 Cefixime 225 97 
Cefoperazone/sulbactam 60 26 Ciprofloxacin 224 96 
 
Ceftazidime  (33%), Ciprofloxacin (37%) and Gentamicin 
(30%). Similar pattern of resistance was observed in 
another study with resistance to ceftazidime (41%),  
 
gentamicin (27%) and ciprofloxacin (26%).24 In our study 
S. aureus was sensitive to Vancomycin & Linezolid (98%). 
S. epidermidis showed 99% sensitivity to  
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Table 2a: Sensitivity and Resistance Pattern of Various Organism (n=228) 
Sensitivity Resistance 
Antibiotic n % Antibiotic n % 
Salmonella Typhi (n=228) 
Ceftriaxone 227 99 Ciprofloxacin 214 94 
Cefixime 222 97 Levofloxacin 212 93 
Ampicillin 99 43 Naladixic acid 200 88 
TMP/SMX 95 42 Ofloxacin 179 79 
Chloramphenicol 77 33 TMP/SMX 133 58 
Enterococcus Faecalis  (n=121) 
Linezolid 121 100 Ceftriaxone 108 89 
Vancomycin 109 90 Ciprofloxacin 108 89 
Amoxillin/clavulanic acid 74 61 Levofloxacin 108 89 
Ampicillin 70 58 Cefixime 107 88 
Nitrofurantoin 55 45 Cephradine 94 78 
Salmonella Paratyphi A  (n=59) 
Cefixime 59 100 Ciprofloxacin 57 97 
Ceftriaxone 59 100 Levofloxacin 57 97 
Ampicillin 54 92 Naladixic acid 57 97 
TMP/SMX 53 90 Ofloxacin 56 95 
Chloramphenicol 50 85 Ampicillin 5 8 
 
Linezolid and 85% to Vancomycin. However, in a study 
conducted in Saudi Arabia it was found that resistant and 
susceptibility profile of S. aureus showed high resistance 
to both ampicillin and linezolid (94.1%) and high 
sensitivity to more than one antibiotic such as 
daptomycin, penicillin, Synercid, teicoplanin, vancomycin, 
and TMP/SMX, which have sensitivity rate more than 
88%.21 E. faecalis which frequently cause urinary tract 
infection, endocarditis and bacteremia, showed resistance 
to generally prescribed  empiric antibiotics regimen like 
Ceftriaxone, Levofloxacin and Ciprofloxacin (89%). E. 
faecalis was sensitive to Linezolid (100%), Vancomycin 
(90%) and Amoxicillin/Clavulanic acid (61%). Linezolid, 
vancomycin and teicoplanin are currently widely used 
drugs for the effective treatment of enterococcal 
infections.25-27 
A baumannii showed sensitivity to Colistin (91%) and 
Tigecyclin (80%), while is resistant to 
Amoxicillin/Clavulanic acid (99%), Ceftriaxone, Ampicillin 
and Cefixime (97%). Therefore, it is sensitive to antibiotics 
prescribed for ventilator associated pneumonia(VAP) (A.  
 
baumannii is a common cause of VAP). Colistin and 
tigecycline are in many cases the unique options for the 
treatment of many episodes of VAP caused by multiple 
drug resistant- gram negative bacteria (MDR-GNB ).28 S. 
typhi and S. paratyphi A showed high degree of 
resistance to Quinolones. Ciprofloxacin (94%), 
Levofloxacin (93%) for S.typhi; Ciprofloxacin and 
Levofloxacin (97%) for S.paratyphi A. Both these 
organisms showed almost no resistance to Ceftiaxone 
and Cefixime. According to a study conducted in 
Islamabad the prevalence of MDR and fluoroquinolone 
resistance was very high among salmonella serovars. No 
resistance was found to third-generation 
cephalosporins.29 
C o n c l u s i o n  
Antibiotic resistance is an emerging problem. Rationale 
use of antibiotics is required to curtail the surge of 
antibiotic resistance. There is also a need to modify 
treatment guidelines in different clinical situations based 
on local sensitivity and resistance patterns. Emphasis  
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stays on reducing hospital stay, morbidity and mortality. 
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